The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
Lang
B
B
Institute of Molecular Medicine, University of Oxford, United Kingdom.
Waterman
S
S
Pinto
A
A
Jones
D
D
Moss
F
F
Boot
J
J
Brust
P
P
Williams
M
M
Stauderman
K
K
Harpold
M
M
Motomura
M
M
Moll
J W
JW
Vincent
A
A
Newsom-Davis
J
J
D000818:Animals; D001323:Autoantibodies / Q000097:blood*; D001341:Autonomic Nervous System / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000378:metabolism; D015220:Calcium Channels / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007116:Immunization, Passive; D015624:Lambert-Eaton Myasthenic Syndrome / Q000097:blood / Q000276:immunology* / Q000503:physiopathology*; D051379:Mice; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000276:immunology; D010455:Peptides / Q000378:metabolism; D012016:Reference Values; D020866:omega-Conotoxin GVIA
D001323:Autoantibodies; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D010455:Peptides; D020866:omega-Conotoxin GVIA